Prospects for a personalized peptide vaccine against lung cancer
Introduction: The tumor characteristics and immunological status of the host should be carefully considered for the successful development of cancer peptide vaccines. Recently, personalized peptide vaccines (PPV) that individually select antigens for each patient are being developed for lung cancer....
Saved in:
Main Authors: | Yoshiro Nakahara (Author), Taku Kouro (Author), Yuka Igarashi (Author), Mamoru Kawahara (Author), Tetsuro Sasada (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2019-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinoma
by: Yosuke Shibata, et al.
Published: (2023) -
Peptide-Based Vaccine against Breast Cancer: Recent Advances and Prospects
by: Muhammad Luqman Nordin, et al.
Published: (2023) -
Immune responses to epidermal growth factor receptor (EGFR) and their application for cancer treatment
by: Tetsuro Sasada, et al.
Published: (2016) -
Personalized vaccination against ovarian cancer: what are the possibilities?
by: Janos L. Tanyi, et al.
Published: (2018) -
Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems
by: Ahmed O. Shalash, et al.
Published: (2022)